Authors Retract Journal Studies On Hydroxychloroquine

The Lancet and New England Journal of Medicine made a big announcement on Thursday.
The news regards the authors of published studies on use of the anti-malarial drug hydroxychloroquine.
The researchers who said Hydroxychloroquine may treat COVID-19 have retracted their findings.
The retractions come after reports questioned the validity of data used in the studies.
Researchers and third-party reviewers could not verify data supplied to them for the study.
One study found COVID patients with cardiovascular disease may even die if treated with the drug.